| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.1B | $12.9B | $12.4B | $12.0B | $12.0B | $4.3B | $3.0B | $2.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $1.8B | $1.3B | $1.3B | $0.8B | $0.1B | $0.3B | $0.2B |
| EPS (Basic) | $4.28 | $9.49 | $6.53 | $6.55 | $4.04 | $0.66 | $1.44 | $1.15 |
| EPS (Diluted) | $4.27 | $9.46 | $6.50 | $6.50 | $4.02 | $0.66 | $1.44 | $1.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $63.5B | $62.0B | $63.3B | $61.4B | $70.1B | $70.6B | $67.0B | $61.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B |
| Total Liabilities | $52.4B | $51.0B | $53.6B | $52.2B | $58.7B | $59.8B | $57.0B | $53.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $11.1B | $11.0B | $9.7B | $9.2B | $11.4B | $10.9B | $10.0B | $8.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $1.5B | $1.2B | $1.4B | $1.4B | $0.6B | $1.7B | $1.5B |
| Investing Cash Flow | $0.5B | $-0.3B | $-0.7B | $-1.0B | $-1.3B | $-0.3B | $-1.4B | $-0.9B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-1.2B | $-1.2B | $-0.5B | $-0.4B | $-0.2B | $-0.2B | $-0.4B | $-0.6B |